The quest to develop an effective therapy for neuroblastoma

Author:

Bhoopathi Praveen12,Mannangatti Padmanabhan1,Emdad Luni123,Das Swadesh K.123,Fisher Paul B.123ORCID

Affiliation:

1. Department of Human and Molecular Genetics, School of Medicine Virginia Commonwealth University Richmond Virginia USA

2. VCU Institute of Molecular Medicine, School of Medicine Virginia Commonwealth University Richmond Virginia USA

3. VCU Massey Cancer Center, School of Medicine Virginia Commonwealth University Richmond Virginia USA

Funder

National Foundation for Cancer Research

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference140 articles.

1. CAR T cells for brain tumors: Lessons learned and road ahead

2. Multiplexed ion beam imaging of human breast tumors;Angelo M.;Nature Medicine (New York, NY, United States),2014

3. Feasibility of High‐dose Iodine‐131‐metaiodobenzylguanidine Therapy for High‐risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: a Study Protocol;Araki R.;Asia Oceania Journal of Nuclear Medicine and Biology,2018

4. Trial Watch

5. Video‐assisted needle core biopsy in children affected by neuroblastoma: A novel combined technique;Avanzini S.;European Journal of Pediatric Surgery,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3